AbstractThe clinical consequence of chronic Pseudomonas aeruginosa colonization in cystic fibrosis (CF) varies between individuals for unknown reasons. Auto-antibodies against bactericidal/permeability increasing protein (BPI-ANCA) are associated with poor prognosis in CF. We hypothesize that there is a correlation between the presence of BPI-ANCA, the properties of the colonizing bacteria and the clinical conditions of the host. We compared isolates of P. aeruginosa from BPI-ANCA positive CF patients who have deteriorating lung disease with BPI-ANCA negative CF patients who are in stable clinical conditions. Epithelial cells (A549) and isolated polymorphonuclear granulocytes (PMNs) were stimulated with the isolates and cell death was analy...
Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF). This...
Pseudomonas aeruginosa causes chronic lung infections in people with cystic fibrosis (CF) and acute ...
Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BP...
Objective. Lung damage is the most common cause of death in cystic fibrosis (CF). It is induced by b...
In cystic fibrosis (CF) colonization of the airways with Pseudomonas aeruginosa is a major cause of ...
Cystic fibrosis (CF) affects 70,000 patients worldwide. Morbidity and mortality in CF is largely cau...
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mort...
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF)...
AbstractBackground:Autoantibodies against bactericidal permeability increasing protein (BPI-ANCA) ar...
Bacterial pathogens and especially Pseudomonas aeruginosa play an important role in cystic fibrosis ...
Pseudomonas aeruginosa is a remarkably versatile environmental bacterium with an extraordinary capac...
Most cystic fibrosis (CF) sufferers will die before reaching their mid thirties as a result of life ...
Patients with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa (P. aeruginosa) have worse ...
© 2014, American Society for Microbiology. Cystic fibrosis (CF) patients have increased susceptibili...
Pseudomonas aeruginosa can establish life-long airways chronic infection in patients with cystic fib...
Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF). This...
Pseudomonas aeruginosa causes chronic lung infections in people with cystic fibrosis (CF) and acute ...
Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BP...
Objective. Lung damage is the most common cause of death in cystic fibrosis (CF). It is induced by b...
In cystic fibrosis (CF) colonization of the airways with Pseudomonas aeruginosa is a major cause of ...
Cystic fibrosis (CF) affects 70,000 patients worldwide. Morbidity and mortality in CF is largely cau...
Chronic endobronchial inflammation and bacterial infection are the main causes of morbidity and mort...
Background. Pseudomonas aeruginosa is a key respiratory pathogen in people with cystic fibrosis (CF)...
AbstractBackground:Autoantibodies against bactericidal permeability increasing protein (BPI-ANCA) ar...
Bacterial pathogens and especially Pseudomonas aeruginosa play an important role in cystic fibrosis ...
Pseudomonas aeruginosa is a remarkably versatile environmental bacterium with an extraordinary capac...
Most cystic fibrosis (CF) sufferers will die before reaching their mid thirties as a result of life ...
Patients with cystic fibrosis (CF) colonized with Pseudomonas aeruginosa (P. aeruginosa) have worse ...
© 2014, American Society for Microbiology. Cystic fibrosis (CF) patients have increased susceptibili...
Pseudomonas aeruginosa can establish life-long airways chronic infection in patients with cystic fib...
Pseudomonas aeruginosa is the leading cause of morbidity and mortality in cystic fibrosis (CF). This...
Pseudomonas aeruginosa causes chronic lung infections in people with cystic fibrosis (CF) and acute ...
Anti-neutrophil cytoplasmic antibodies specific for bactericidal/permeability-increasing protein (BP...